Acasti Pharma  logo
Acasti Pharma ACST
$ 3.37 4.01%

Quarterly report 2024-Q3
added 11-13-2024

report update icon

Acasti Pharma ROCE Ratio 2011-2024 | ACST

Annual ROCE Ratio Acasti Pharma

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-76.75 -14.4 -29.5 - -145.66 -121.12 -48.79 -35.11 -34.83 -24.29 -71.78 -45.01 -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
-14.4 -145.66 -58.84

Quarterly ROCE Ratio Acasti Pharma

2024-Q3 2024-Q2 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
-24.81 -23.16 -19.19 -18.87 -20.84 -14.02 -18.05 -17.69 -22.38 -26.38 -34.02 -37.63 -35.47 -105.82 -143.16 7.74 839.49 685.57 722.92 579.65 -244.46 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
839.49 -244.46 96.64